| Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018) K Haider, S Rahaman, MS Yar, A Kamal Expert opinion on therapeutic patents 29 (8), 623-641, 2019 | 102 | 2019 |
| Free radical scavengers: An overview on heterocyclic advances and medicinal prospects K Haider, MR Haider, K Neha, MS Yar European Journal of Medicinal Chemistry 204, 112607, 2020 | 87 | 2020 |
| Aromatase inhibitors: Role in postmenopausal breast cancer R Kharb, K Haider, K Neha, MS Yar Archiv Der Pharmazie 353 (8), 2000081, 2020 | 76 | 2020 |
| A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents K Haider, M Shafeeque, S Yahya, MS Yar European Journal of Medicinal Chemistry Reports 5, 100042, 2022 | 55 | 2022 |
| DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective A Pathak, A Rohilla, T Gupta, MJ Akhtar, MR Haider, K Sharma, K Haider, ... European Journal of Medicinal Chemistry 158, 559-592, 2018 | 47 | 2018 |
| Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review K Haider, A Pathak, A Rohilla, MR Haider, K Ahmad, MS Yar European journal of medicinal chemistry 184, 111773, 2019 | 37 | 2019 |
| Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer N Hasan, M Imran, M Nadeem, D Jain, K Haider, MMA Rizvi, A Sheikh, ... International journal of pharmaceutics 632, 122580, 2023 | 35 | 2023 |
| An appraisal of anticancer activity with structure–activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A review K Haider, S Das, A Joseph, MS Yar Drug Development Research 83 (4), 859-890, 2022 | 29 | 2022 |
| Recent advances and SAR study of 2-substituted benzothiazole scaffold based potent chemotherapeutic agents K Haider, N Shrivastava, A Pathak, RP Dewangan, S Yahya, MS Yar Results in Chemistry 4, 100258, 2022 | 28 | 2022 |
| Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents K Haider, S Rehman, A Pathak, AK Najmi, MS Yar Archiv der Pharmazie 354 (12), 2100246, 2021 | 28 | 2021 |
| Synthetic lethality on drug discovery: an update on cancer therapy MS Yar, K Haider, V Gohel, NA Siddiqui, A Kamal Expert Opinion on Drug Discovery 15 (7), 823-832, 2020 | 22 | 2020 |
| Synthetic approaches for oxazole derivatives: A review SKSW Kumari Neha, Faraat Ali, Kashif Haider Synthetic Communications, 2021 | 19 | 2021 |
| Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and Resveratrol to Alzheimer's disease: Synthesis, in vitro characterization and brain … D Jain, N Hasan, S Zafar, J Thakur, K Haider, S Parvez, FJ Ahmad Journal of Drug Delivery Science and Technology 86, 104555, 2023 | 15 | 2023 |
| Advances of benzimidazole derivatives as anticancer agents: bench to bedside K Haider, MS Yar Benzimidazole, 162, 2022 | 15 | 2022 |
| Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents A Pathak, V Pandey, YR Pokharel, V Devaraji, A Ali, K Haider, S Saad, ... Bioorganic Chemistry 116, 105358, 2021 | 11 | 2021 |
| Design, synthesis, biological evaluation, and in silico studies of 2‐aminobenzothiazole derivatives as potent PI3Kα inhibitors K Haider, K Ahmad, AK Najmi, S Das, A Joseph, M Shahar Yar Archiv der Pharmazie 355 (10), 2200146, 2022 | 9 | 2022 |
| Synthesis, biological evaluation, and in silico studies of indole‐tethered pyrazoline derivatives as anticancer agents targeting topoisomerase IIα K Haider, S Sharma, YR Pokharel, S Das, A Joseph, AK Najmi, F Ahmad, ... Drug Development Research 83 (7), 1555-1577, 2022 | 7 | 2022 |
| Novel approaches for the development of direct KRAS inhibitors: structural insights and drug design K Haider, A Sharma, MS Yar, PA Yakkala, S Shafi, A Kamal Expert Opinion on Drug Discovery 17 (3), 247-257, 2022 | 6 | 2022 |
| Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials AK Singh, A Vidyadhari, H Singh, K Haider, A Kumar, M Sharma Clinical Epidemiology and Global Health 16, 101097, 2022 | 4 | 2022 |
| Design, in-silico study and biological evaluation of newly synthesized 3-chlorobenzofuran congeners as antitubercular agents MM Abdullah, NA Siddiqui, RA Mothana, FA Nasr, AJ Al-Rehaily, ... Arabian Journal of Chemistry 14 (4), 103034, 2021 | 4 | 2021 |
Mohammad Shahar Yar, ProfessorJamia Hamdard在 jamiahamdard.ac.in 的电子邮件经过验证
